Figure 7. OLA1 is a potential prognostic biomarker for patients with breast cancer.
(A) Representative micrographs of IHC staining of OLA1 in human breast cancer tissues. Expression of OLA1 was scored (0–3). (B) Kaplan-Meier analysis for breast cancer relapse in all patients (left panel) and those undergoing adjuvant chemotherapy (right panel). Lower expression of OLA1 indicates more relapse in patients. (C) Kaplan-Meier analysis for DSS in all patients (left panel) and those undergoing adjuvant chemotherapy (right panel). Lower expression of OLA1 indicates worse DSS in patients.